Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma
Publication year
2021Source
The New England Journal of Medicine, 384, 22, (2021), pp. 2102-2114ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Urology
Journal title
The New England Journal of Medicine
Volume
vol. 384
Issue
iss. 22
Page start
p. 2102
Page end
p. 2114
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 15: Urological cancers RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [234412]
- Electronic publications [117392]
- Faculty of Medical Sciences [89250]
- Open Access publications [84336]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.